A retrospective natural history study of visual function in subjects with inherited retinal disease treated with zuretinol acetate

Trial Profile

A retrospective natural history study of visual function in subjects with inherited retinal disease treated with zuretinol acetate

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 May 2017

At a glance

  • Drugs Zuretinol acetate (Primary)
  • Indications Leber congenital amaurosis; Retinitis pigmentosa
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 May 2017 Results(n=25) published in the Novelion Therapeutics media release.
    • 09 May 2017 According to a Novelion Therapeutics media release, data from this trial presented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2017.
    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top